- Home
- SM vs BLTE Comparison
SM vs BLTE Comparison
Compare SM & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SM
- BLTE
- Stock Information
- Founded
- SM 1908
- BLTE 2018
- Country
- SM United States
- BLTE United States
- Employees
- SM N/A
- BLTE N/A
- Industry
- SM Oil & Gas Production
- BLTE Biotechnology: Pharmaceutical Preparations
- Sector
- SM Energy
- BLTE Health Care
- Exchange
- SM Nasdaq
- BLTE Nasdaq
- Market Cap
- SM 2.3B
- BLTE 2.1B
- IPO Year
- SM 1992
- BLTE 2022
- Fundamental
- Price
- SM $23.03
- BLTE $56.40
- Analyst Decision
- SM Buy
- BLTE Strong Buy
- Analyst Count
- SM 11
- BLTE 4
- Target Price
- SM $48.50
- BLTE $96.67
- AVG Volume (30 Days)
- SM 3.1M
- BLTE 37.7K
- Earning Date
- SM 05-01-2025
- BLTE 05-12-2025
- Dividend Yield
- SM 3.58%
- BLTE N/A
- EPS Growth
- SM N/A
- BLTE N/A
- EPS
- SM 6.67
- BLTE N/A
- Revenue
- SM $2,574,259,000.00
- BLTE N/A
- Revenue This Year
- SM $36.51
- BLTE N/A
- Revenue Next Year
- SM $0.34
- BLTE N/A
- P/E Ratio
- SM $3.45
- BLTE N/A
- Revenue Growth
- SM 13.46
- BLTE N/A
- 52 Week Low
- SM $19.67
- BLTE $32.25
- 52 Week High
- SM $51.94
- BLTE $86.53
- Technical
- Relative Strength Index (RSI)
- SM 39.38
- BLTE 39.21
- Support Level
- SM $20.51
- BLTE $49.00
- Resistance Level
- SM $22.66
- BLTE $60.21
- Average True Range (ATR)
- SM 2.13
- BLTE 3.55
- MACD
- SM -0.08
- BLTE -0.57
- Stochastic Oscillator
- SM 30.41
- BLTE 41.67
About SM SM Energy Company
SM Energy Co is an independent energy company engaged in the acquisition, exploration, development, and production of oil, gas, and NGLs in Texas and Utah. Its portfolio is comprised of assets in the Midland Basin of West Texas, the Maverick Basin of South Texas, and the Uinta Basin of northeastern Utah.
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.